HEART Editorial: High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action

Posted April 30, 2020April 30, 2020 Alan Reid

Editorial from Andrew Chapman and Nick Mills

View Article

⟵Troponins Touted as ‘Ally’ in COVID-19 Triage

NT-proBNP Commentary (Distribution 264)⟶

Upcoming Events

Distribution 284 – Final Date for Input of Results

February 2
Distribution 285 – Distribution Opens

February 7
Distribution 284 – Report Issued (week beginning)

February 7

View All Events

Get In Touch

Level 1 (Room B/046), Laboratory Medicine & Facilities Management Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF

+44 (0)141 440 2888

info@ukneqas-cm.org.uk

About UKNEQAS

Since 1969 the United Kingdom National External Quality Assessment Service (UK NEQAS) has been providing a comprehensive world-wide service that enables laboratories to fulfil quality goals and facilitate optimal patient care. UK NEQAS now comprises a network of 390 schemes operating from 26 centres based at major hospitals, research institutions and universities throughout the UK.

NHS Greater Glasgow & Clyde, operating UK NEQAS Cardiac Markers, is a UKAS accredited proficiency testing provider (No:8560)(BS EN ISO/IEC 17043:2010). We are a non-profit centre working within NHS Greater Glasgow and Clyde to improve cardiac biomarker investigations in the clinical laboratory sector for the benefit of patients.

Get in touch

Level 1 (Room B/046), Laboratory Medicine & Facilities Management Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF

+44 (0)141 440 2888

info@ukneqas-cm.org.uk